Wen‐Hwa Lee
Impact in
- Oncology top 0.1%
- Cancer-related Molecular Pathways
- Ophthalmology top 0.1%
- Ocular Oncology and Treatments
Papers in
-
- Ocular Oncology and Treatments 34
- Oncology 82
- Cancer-related Molecular Pathways 60
- Co-authors
- Phang‐Lang ChenEva Y.-H.P. LeeRobert BooksteinJin‐Yuh ShewYumay ChenPeter ScullyChi‐Fen ChenLei Zheng
- Journals
- Journal of Biological Chemistry (21 papers)Proceedings of the National Academy of Sciences (16 papers)PLoS ONE (14 papers)Toxicon (13 papers)Molecular and Cellular Biology (13 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Wen‐Hwa Lee
255 papers receiving 20.2k citations
Hit Papers
Peers
Comparison fields: 5 of 189
- Oncology 8.0k
- Ophthalmology 2.4k
- Molecular Biology 13.9k
- Genetics 4.8k
- Cancer Research 2.4k
Countries citing papers authored by Wen‐Hwa Lee
This map shows the geographic impact of Wen‐Hwa Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Hwa Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Hwa Lee more than expected).
Fields of papers citing papers by Wen‐Hwa Lee
This network shows the impact of papers produced by Wen‐Hwa Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Hwa Lee. The network helps show where Wen‐Hwa Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Wen‐Hwa Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2021 | 28 | |
| 3 | 2020 | 17 | |
| 4 | 2019 | 7 | |
| 5 | 2019 | 17 | |
| 6 | 2013 | 12 | |
| 7 | 2012 | 115 | |
| 8 | 2010 | 191 | |
| 9 | 2009 | 47 | |
| 10 | 2008 | 92 | |
| 11 | [Status of vaccination against hepatitis B among postgraduate students in medical higher education institutions in Guangzhou]. | 2007 | 2 |
| 12 | 2003 | 102 | |
| 13 | BRCA2 Function in DNA Binding and Recombination from a BRCA2-DSS1-ssDNA Structure Hit paper breakdown → | 2002 | 549 |
| 14 | 2002 | 14 | |
| 15 | Perturbation of TSG101 protein affects cell cycle progression. | 1998 | 47 |
| 16 | Identification of cellular TSG101 protein in multiple human breast cancer cell lines. | 1997 | 19 |
| 17 | 1996 | 154 | |
| 18 | 1995 | 124 | |
| 19 | 1995 | 11 | |
| 20 | 1994 | 4 |
About Wen‐Hwa Lee
Wen‐Hwa Lee is a scholar working on Ophthalmology, Oncology, Genetics, Molecular Biology and Immunology, having authored 257 papers that have together received 20.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (60 papers), Ocular Oncology and Treatments (34 papers), DNA Repair Mechanisms (31 papers), Genomics and Chromatin Dynamics (20 papers), Venomous Animal Envenomation and Studies (20 papers), CRISPR and Genetic Engineering (17 papers), Virus-based gene therapy research (17 papers) and BRCA gene mutations in cancer (15 papers). The work is most often cited by research in Oncology (8.0k citations), Ophthalmology (2.4k citations), Molecular Biology (13.9k citations), Genetics (4.8k citations) and Cancer Research (2.4k citations). Wen‐Hwa Lee has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Phang‐Lang Chen, Eva Y.-H.P. Lee, Robert Bookstein, Jin‐Yuh Shew, Yumay Chen, Peter Scully, Chi‐Fen Chen, Lei Zheng, Frank Hong and Z. Dave Sharp. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, PLoS ONE, Toxicon and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.